A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments
There is a growing understanding as science evolves that different cancer types require different approaches to treatment evaluation, especially in the metastatic stages. The introduction of new metastatic breast cancer (MBC) treatments may be hindered by several elements, including the availability...
| Autori principali: | , , , , , , , , , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Elsevier
2020-08-01
|
| Serie: | Breast |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S0960977620301077 |